Synlogic Appoints Dr. Antoine Yver as Chief Medical Officer

Ticker: SYBX · Form: 8-K · Filed: Feb 21, 2025 · CIK: 1527599

Synlogic, Inc. 8-K Filing Summary
FieldDetail
CompanySynlogic, Inc. (SYBX)
Form Type8-K
Filed DateFeb 21, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: management-change, cmo-appointment, biotech

TL;DR

Synlogic just hired a new CMO, Dr. Antoine Yver. Big move for their drug pipeline.

AI Summary

On February 20, 2025, Synlogic, Inc. announced the appointment of Dr. Antoine Yver as Chief Medical Officer. Dr. Yver previously served as Chief Medical Officer at Imago BioSciences, Inc. and has extensive experience in clinical development and regulatory affairs.

Why It Matters

The appointment of a new Chief Medical Officer is a significant leadership change that could impact the company's drug development strategy and clinical trial progress.

Risk Assessment

Risk Level: medium — The appointment of a new CMO is a key leadership change that could signal shifts in strategic direction or development progress, impacting the company's future success.

Key Players & Entities

  • Synlogic, Inc. (company) — Registrant
  • Dr. Antoine Yver (person) — Appointed Chief Medical Officer
  • Imago BioSciences, Inc. (company) — Dr. Yver's previous employer
  • February 20, 2025 (date) — Date of earliest event reported

FAQ

What is the effective date of Dr. Antoine Yver's appointment as Chief Medical Officer?

The filing reports the earliest event on February 20, 2025, which is when the appointment would have been effective or announced.

What was Dr. Antoine Yver's previous role before joining Synlogic, Inc.?

Dr. Yver previously served as Chief Medical Officer at Imago BioSciences, Inc.

What is Synlogic, Inc.'s primary business sector?

Synlogic, Inc. is in the Pharmaceutical Preparations sector, with Standard Industrial Classification code 2834.

Where is Synlogic, Inc. headquartered?

Synlogic, Inc.'s principal executive offices are located at PO Box 30, Winchester, Massachusetts, 01890.

What is the Commission File Number for Synlogic, Inc.?

Synlogic, Inc.'s Commission File Number is 001-37566.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on February 21, 2025 by Dr. Antoine Yver regarding SYNLOGIC, INC. (SYBX).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.